半年融两轮，柳叶刀机器人完成数千万元A+轮融资

Core Insights - Shenzhen Liuyedao Robot Co., Ltd. has completed a multi-million yuan A+ round of financing led by Yuehu Fund, aimed at enhancing its position in the domestic surgical robot market [1] - The company focuses on providing comprehensive AI surgical robot solutions for medical institutions, having developed a complete product and service system covering multiple key clinical areas [2] - Liuyedao Robot has achieved 100% localization of core components, significantly reducing production costs and promoting the widespread adoption of high-end surgical robots in various healthcare settings [3] Company Developments - The company has obtained multiple medical device registrations, including five Class III medical device certificates and one FDA 510(k) registration, showcasing its strong regulatory compliance [2] - Liuyedao Robot's products are currently in use in dozens of hospitals, facilitating the accessibility of robotic-assisted surgeries in grassroots medical institutions [3] - The chairman expressed gratitude for the support from Yuehu Fund and emphasized the company's commitment to accelerating the registration and market introduction of its surgical robots [5] Technological Advancements - The company has made significant breakthroughs in core technologies, achieving full domestic production of surgical robot components, which has disrupted the market previously dominated by imported products [5] - The RobPath-THA robot has achieved a 96.6% accuracy rate in acetabular installation, setting a new industry standard [6] - Liuyedao Robot's non-closed platform design and its integrated business model of "equipment + consumables + services" have created a new paradigm for medical technology development [6] Market Positioning - Established in 2018, Liuyedao Robot is positioned in four key surgical fields: spine/trauma, joint replacement, oral implantation, and vascular intervention [7] - The company collaborates with renowned medical institutions to create a robust research and innovation platform, enhancing its capabilities in medical engineering integration [7] - The financing will support the company's expansion into global markets and the development of new products, reinforcing its status as an industry benchmark [5]